Monoclonal antibodies inhibiting IL-12, -23, and -17 for the treatment of psoriasis

• Principais autores: Caleb Jeon (Autor), Sahil Sekhon (Autor), Di Yan (Autor), Ladan Afifi (Autor), Mio Nakamura (Autor), Tina Bhutani (Autor)
• Formato: Livro
• Publicado em: Taylor & Francis Group, 2017-10-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Psoriasis is a chronic, inflammatory, immune-mediated skin condition that affects 3 to 4% of the adult US population, characterized by well-demarcated, erythematous plaques with silver scale. Psoriasis is associated with many comorbidities including cardiometabolic disease and can have a negative im...